Importantly, cessation of tacrolimus injection 7 days after allogeneic cell transplantation, when malignant teratocarcinomas were present, diminished the progression of the teratocarcinoma formation in combination with accumulation of CD4 and CD8-positive T cells, resulting in the complete loss of the teratocarcinoma. The gene discussed is CD4; the disease is teratocarcinoma.